Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morris Zwi

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|November 8, 2008
Injury and attention deficit hyperactivity disorderMorris Zwi, Philip Clamp
American Family Physician|May 20, 2003
Attention-deficit/hyperactivity disorderCarol Joughin, Paul Ramchandani, Morris Zwi
Clinical Evidence|September 12, 2003
Attention deficit hyperactivity disorderPaul Ramchandani, Carol Joughin, Morris Zwi
Clinical Evidence|September 17, 2002
Attention deficit hyperactivity disorder in childrenPaul Ramchandani, Carol Joughin, Morris Zwi
Clinical Evidence|February 27, 2003
Attention deficit hyperactivity disorder in childrenPaul Ramchandani, Carol Joughin, Morris Zwi
The Cochrane Database of Systematic Reviews|December 14, 2011
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 yearsMorris Zwi, Hannah Jones, Camilla Thorgaard, et al.
The Cochrane Database of Systematic Reviews|November 25, 2014
Parent training interventions for attention deficit hyperactivity disorderMorris Zwi, Hannah Jones, Camilla Thorgaard, et al.
Clinical Pharmacology and Therapeutics|July 15, 2018
The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention-Deficit/Hyperactivity DisorderOle Jakob Storebø, Erlend Faltinsen, Morris Zwi, et al.
The Lancet. Psychiatry|November 8, 2018
Unbalanced risk-benefit analysis of ADHD drugsErlend G Faltinsen, Christian Gluud, Erik Simonsen, et al.
BMJ Evidence-Based Medicine|December 12, 2018
Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical lookErlend Faltinsen, Morris Zwi, Xavier Castells, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|November 8, 2008
Injury and attention deficit hyperactivity disorderMorris Zwi, Philip Clamp
American Family Physician|May 20, 2003
Attention-deficit/hyperactivity disorderCarol Joughin, Paul Ramchandani, Morris Zwi
Clinical Evidence|September 12, 2003
Attention deficit hyperactivity disorderPaul Ramchandani, Carol Joughin, Morris Zwi
Clinical Evidence|September 17, 2002
Attention deficit hyperactivity disorder in childrenPaul Ramchandani, Carol Joughin, Morris Zwi
Clinical Evidence|February 27, 2003
Attention deficit hyperactivity disorder in childrenPaul Ramchandani, Carol Joughin, Morris Zwi
The Cochrane Database of Systematic Reviews|December 14, 2011
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 yearsMorris Zwi, Hannah Jones, Camilla Thorgaard, et al.
The Cochrane Database of Systematic Reviews|November 25, 2014
Parent training interventions for attention deficit hyperactivity disorderMorris Zwi, Hannah Jones, Camilla Thorgaard, et al.
Clinical Pharmacology and Therapeutics|July 15, 2018
The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention-Deficit/Hyperactivity DisorderOle Jakob Storebø, Erlend Faltinsen, Morris Zwi, et al.
The Lancet. Psychiatry|November 8, 2018
Unbalanced risk-benefit analysis of ADHD drugsErlend G Faltinsen, Christian Gluud, Erik Simonsen, et al.
BMJ Evidence-Based Medicine|December 12, 2018
Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical lookErlend Faltinsen, Morris Zwi, Xavier Castells, et al.
Pageof 2